North Korea - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, North Korea Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 64.2% year on year. In 2019, the country was ranked number 27 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 2,354 Cases. North Korea is overtaken by Nigeria, which was number 26 with 2,384 Cases and is followed by Uzbekistan at 2,060 Cases. India topped the ranking with 66,255 Cases in 2019, that is an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 2,354.00 |
| 2018 | 1,782.00 |
| 2017 | 1,515.00 |
| 2016 | 935.00 |
| 2015 | 209.00 |
How does North Korea rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 25 |
#25
Uzbekistan
|
2,405 | 2019 | +2.4 % | -8.9 % | View data | |
| 27 |
#27
North Korea
|
2,354 | 2019 | +32.1 % | +64.2 % | View data | |
| 29 |
#29
Peru
|
1,894 | 2019 | -2.5 % | +5.3 % | View data | |